Serum ceramides could predict durable diabetes remission following gastric bypass surgery - Sorbonne Université Access content directly
Journal Articles Med Year : 2022

Serum ceramides could predict durable diabetes remission following gastric bypass surgery

Abstract

Morbid obesity is a major risk factor for the development of type 2 diabetes (T2D). One strategy to both lose weight and counteract T2D is bariatric surgery (RYGB). In a study published in this issue of Med, Poss et al. revealed that circulating ceramides could predict the durability of T2D remission independently of weight loss following RYGB.

Dates and versions

hal-04191090 , version 1 (30-08-2023)

Identifiers

Cite

Eric Hajduch, Hervé Le Stunff. Serum ceramides could predict durable diabetes remission following gastric bypass surgery. Med, 2022, 3 (7), pp.440-441. ⟨10.1016/j.medj.2022.06.005⟩. ⟨hal-04191090⟩
23 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More